Global Health

IDSA prioritizes promoting sufficient US investment in global infectious diseases responses and research, and in using the voices of physician scientists to inform multilateral and national global health policies. IDSA is a trusted leader in shaping and advancing international and national policies and investments in global HIV, TB, health security and antimicrobial resistance.

House FY 2020 Appropriations Respond to Most Infectious Disease and HIV Realities
6/20/2019
With increased funds for important federal programs and interventions responding to infectious diseases and HIV, the health, foreign operations, and defense spending bill for fiscal year 2020 passed by the House of Representatives Wednesday reflects an understanding of a broad scope of public health threats at home and around the world, and of the resources needed to address them.
Click here to read more.

Cross-Border Spread of DCR Ebola Outbreak Calls for Immediate, Ongoing Responses
6/12/2019
Uganda health officials’ confirmation today of Ebola virus among family members who travelled from the Democratic Republic of Congo brings with it the realization of a concern that has been noted since the August 2018 recognition of the current outbreak.
Click here to read more.

IDSA Floor Statement for World Health Assembly 72 on Health, Environment, and Climate Change
5/17/2019
IDSA floor statement for World Health Assembly 72 on health, environment, and climate change.
Click here to read more.

IDSA Floor Statement for World Health Assembly 72 on TB and AMR
5/17/2019
IDSA floor statement for World Health Assembly 72 on TB and antimicrobial resistance.
Click here to read more.

Spending Bill Recognizes Crucial Global Health Goals
2/15/2019
The 2019 spending bill passed by the House and Senate Thursday that the President has announced he will sign, reflects a meaningful commitment to moving our country forward and to continued U.S. leadership of the fight against the world’s most devastating infectious disease killers.
Click here to read more.

Congress Recognizes Value of PEPFAR with Reauthorization; Funding Increases will be Critical
11/29/2018
The Senate's approval reauthorizing PEPFAR acknowledges the program's role in reversing the trajectory of the AIDS pandemic and boosting responses against ID worldwide.
Click here to read more.

IDSA Urges Strengthened U.S. Leadership of Global Health Security Agenda 11/6/2018
As Global Health Security Agenda partners meet in Indonesia this week to commit to their next steps in improving epidemic readiness worldwide, the Infectious Diseases Society of America is asking the U.S. Department of Health and Human Services to strengthen its leadership of efforts through the partnership.
Click here to read more.

Bills Support Crucial Public, Global Health, and Research Priorities

6/15/18

World Bank, IMF must Focus on Global Health Funding and Capacity 4/20/2018
The Infectious Diseases Society of America appreciates the attention that the World Bank and International Monetary Fund will give to critical global health issues during their spring meetings and civil society forum.
Click here to read more.

House Testimony on Global Health Programs 4/20/2018
IDSA urges for increased funding for State Department and USAID global health programs in this testimony submitted to the House Appropriations Committee.
Click here to read more.

Hank Tomlinson, Ph.D. to Lead CDC’s Global HIV and TB Efforts at Critical Time 4/18/2018
The U.S. government response to the global impacts of HIV and tuberculosis is poised at a pivotal moment, in which we can seize the opportunity to end these devastating pandemics, or watch progress erode, infections increase, and our effective treatments compromised by growing drug resistance.
Click here to read more.

PEPFAR report serves as a beacon and a warning 4/12/2018
The 2018 Annual Report to Congress released by the United States President’s
Emergency Plan for AIDS Relief (PEPFAR) tells a story of remarkable progress and opportunity. Click here to read more.

Statement on World Health Day 04/20/2018
On World Health Day, the Infectious Diseases Society of America and the
HIV Medicine Association appreciate the global leadership of the United States
in responding to infectious disease threats that know no boundaries.
Click here to read more.
Click here for IDSA/HIVMA Global Impact: 2018 and Beyond.

Statement on World TB Day 03/23/2018
Commemoration of World TB Day finds us at a promising but pivotal moment. Advances in diagnostic tools, medications, and treatment regimens are offering significant improvements to detect, treat and control tuberculosis. Click here to read more.

Cross-Border Spread of DCR Ebola Outbreak Calls for Immediate, Ongoing Responses

6/12/2019

Uganda health officials’ confirmation today of Ebola virus among family members who travelled from the Democratic Republic of Congo brings with it the realization of a concern that has been noted since the August 2018 recognition of the current outbreak.

IDSA Floor Statement for World Health Assembly 72 on Health, Environment, and Climate Change (PDF)

5/17/2019

IDSA floor statement for World Health Assembly 72 on health, environment, and climate change.

IDSA Floor Statements for World Health Assembly 72 on TB and AMR (PDF)

5/17/2019

IDSA floor statement for World Health Assembly 72 on TB and antimicrobial resistance.

Spending Bill Recognizes Crucial Global Health Goals

2/15/2019

The 2019 spending bill passed by the House and Senate Thursday that the President has announced he will sign, reflects a meaningful commitment to moving our country forward and to continued U.S. leadership of the fight against the world’s most devastating infectious disease killers.

WHO/CDC Report on Global Measles Shows Toll of Vaccine Gaps

12/5/2018

New report documents a steep climb in measles cases with severe outbreaks worldwide linked to vaccine coverage gaps indicates stalled momentum in efforts to control a preventable and deadly disease.

United Nations High-Level Meeting on TB Offers Chance to End Global Threat

9/26/2018

The United Nations General Assembly’s first high-level meeting on tuberculosis this week opens the opportunity for international collaboration and commitment toward ending the impacts of the world’s leading infectious disease killer.

Global Health Leaders Celebrate PEPFAR, Call for Increased Support

9/21/2018

Leaders of research and programmatic responses to HIV globally gathered on Capitol Hill Thursday to celebrate the 15th anniversary of the President’s Emergency Plan for AIDS Relief launch and the flagship program’s achievements, but also to cite urgent needs to strengthen and accelerate the program’s efforts toward ending the pandemic.

Subcommittee Hearing Will Present Lawmakers with TB Response Needs

7/12/2018

House Foreign Affairs Africa, Global Health, Global Human Rights and International Organization subcommittee members today will hear from global health leaders on tuberculosis challenges for the first time in the nearly three years since the World Health Organization announced the disease has become the world’s leading infectious killer.

Boosts for PEPFAR, TB Reflect Leadership and Commitment

6/25/2018

The spending bill released Friday by the Senate Appropriations State and Foreign Operations subcommittee, proposing the first increase in funding for the U.S. President’s Emergency Plan for AIDS Relief in nearly a decade, and the robust increase proposed by the House Appropriations State and Foreign Operations subcommittee for USAID’s global efforts to combat tuberculosis, demonstrate a welcome awareness of the tremendous value of continued U.S. leadership of crucial global health responses.

DRC Ebola Outbreak Demonstrates Need for Continued Investments

5/21/2018

The Ebola outbreak in the Democratic Republic of Congo announced May 8 has highlighted meaningful advances as well as critical needs that continue in the wake of the epidemic across Sierra Leone, Guinea and Liberia that ended two years ago.

Physicians, scientists urge U.S. leadership in UN Meeting on TB

5/21/2018

More than 900 physicians, scientists and researchers confronting tuberculosis across communities in the United States and around the world have signed a letter urging U.S. Ambassador to the United Nations Nikki Haley to ensure that the September UN General Assembly High Level Meeting Ending Tuberculosis leads to concrete commitments aimed at eliminating the impacts of the world’s leading infectious disease killer.

Congress Recognizes Value of PEPFAR with Reauthorization; Funding Increases will be Critical

11/29/2018

The Senate's approval reauthorizing PEPFAR acknowledges the program's role in reversing the trajectory of the AIDS pandemic and boosting responses against ID worldwide.

House Testimony on Global Health Programs (PDF)

4/20/2018

IDSA urges for increased funding for State Department and USAID global health programs in this testimony submitted to the House Appropriations Committee.

Statement on World AIDS Day 2017

12/1/2017

On World AIDS Day, while we recognize the progress made against HIV globally, we must measure that progress against the urgent needs that remain.

Global Center Statement on President's FY 2017 Budget (PDF)

2/11/2016

As physician scientists confronting the global TB and HIV pandemics, we were excited last September to see the Obama Administration set new treatment and prevention goals for the President’s Emergency Plan for AIDS Relief.

Commemorate Progress, Seize Opportunities on World TB Day (PDF)

3/23/2016

We commemorate World TB Day faced with unprecedented challenges and opportunities in the fight against a disease first named 134 years ago today.

Statement on WHO 2016 Global TB Report (PDF)

10/13/2016

Today the World Health Organization released new data showing that the tuberculosis (TB) epidemic is worse than previously known, with over 10 million people falling sick last year.

IDSA Comments to UN IACG on AMR on Draft Recommendations

2/25/2019

IDSA comments to the United Nations Interagency Coordination Group on Antimicrobial Resistance draft recommendations. IDSA supports the IACG draft recommendations and offers perspectives to help emphasize the importance of specific recommendations and ideas to further strengthen and operationalize the recommendations.

Bills Support Crucial Public, Global Health, and Research Priorities

6/15/2018

House appropriators soundly rejected White House proposals for global and domestic health program and biomedical research funding cuts that would threaten decades of progress in controlling infectious diseases.

IDSA Presents Priorities at World Health Assembly

5/29/2018

IDSA Presents Priorities at World Health Assembly 2018-05-29 The Infectious Diseases Society of America participated in the 71st World Health Assembly in Geneva during the week of May 21 -25, presenting and joining statements reflecting IDSA priorities.

IDSA Comments on Healthy People 2030 (PDF)

1/17/2019

IDSA comments to the Department of Health and Human Services' Secretary's Advisory Committee on National Health and Disease Prevention proposed objectives for Healthy People in the areas of global health, healthcare-associated infections, immunization and infectious disease, opioids, and sexually transmitted diseases.

Joint Letter to Office of US Global AIDS Coordinator and Health Diplomacy on Need for IPT Data (PDF)

10/5/2016

Letter to Senate Leaders on Military Medical Research (PDF)

6/1/2016

Joint Letter on FDA Priority Review Voucher Program (PDF)

5/19/2016

Report on CROI 2017 (PDF)

5/11/2017

Launched in 1993 as a forum for basic scientists and clinical investigators from around the world to share and discuss laboratory science, clinical trials and evolving practice confronting HIV and its associated impacts, the Conference on Retroviruses and Opportunistic Infections has provided the setting for presentations of landmark research heralding advances against the pandemic.

Report on 47th Union World Conference on Lung Health (PDF)

5/11/2017

The resistance that enabled tuberculosis to resurge from a sickness considered all but conquered in the last century, to one that in this century kills more people than any other infectious disease on earth, goes beyond the mutations of the bacteria that survive initial treatment.

Fogarty International Center (PDF)

4/26/2017

The Fogarty International Center, founded in 1968 and part of the National Institutes of Health, connects American scientists and health-care professionals with their global health peers to support basic, clinical, and applied research along with training programs in low-and middle-income countries.

Updated Zika White Paper 2017 (PDF)

4/26/2017

Before the 2015 arrival of Zika virus in the Western Hemisphere, a mosquito bite had never before been linked to a devastating birth defect.

New White Paper on Tuberculosis (PDF)

1/11/2017

About a third of the world’s population is infected with the bacterium that causes active, infectious tuberculosis disease. While 90 percent of infected people will not progress to disease, people with compromised immune systems, including from HIV, face much greater risks of illness.

New White Paper on Global Antimicrobial Resistance (PDF)

9/30/2016

The development of medicines that control bacteria, viruses, parasites and fungi ushered in the era of modern medicine over the last century.

Report on 2016 International AIDS Conference (PDF)

8/18/2016

The 2016 International AIDS Conference returned to the South African city and to a country that is home to the largest HIV treatment program in the world, while more than 17 million people globally are accessing antiretroviral treatment.

New White Paper on HIV (PDF)

4/25/2016

Since surfacing in 1981, the global HIV pandemic is estimated to have infected 78 million people, killed 39 million, left more than 17 million orphans, reversed an upward trend in life expectancy around the world, and, in the process, turned the clock back on health systems, education and economic development in some of the poorest countries in the world. Today, more than 37 million people worldwide are infected with HIV.

New White Paper on Zika (PDF)

4/20/2016

Before the 2015 arrival of Zika virus in the Western Hemisphere, a mosquito bite had never before been linked to a devastating birth defect.

Redeployment: Opportunities to Control HIV and TB in Tanzania (PDF)

4/30/2015

The Infectious Diseases Society of America Education and Research Foundation Center for Global Health Policy hosted five Congressional staff delegates on a visit to Tanzania in October 2014 to witness the impacts of United States investments in responses to the HIV and tuberculosis epidemics there, and to discover obstacles to prevention and treatment of those diseases in the country.

Countdown: Global HIV, Responses, Results

This briefing paper from IDSA chronicles the progress made over the past decade in eliminating HIV/AIDS as a global public health threat, and looks ahead at the work that remains in achieving epidemic control.

Global Health Careers

In an interconnected world where an infectious disease outbreak in a developing country is just a plane ride away from major cities around the world, ID physicians and researchers have an increasingly important role to play in global health. This document outlines opportunities and issues to consider for ID professionals interested in advancing global health responses and research.

Red Ribbon or White Flag? The Future of the US Global AIDS Response (PDF)

12/1/2017

This report from the ONE campaign details the impacts of the White House’s proposed budget cuts to US global HIV funding and subsequent PEPFAR strategy on the global AIDS response.

The Ascent Begins: Tuberculosis Research Funding Trends, 2005-2016

11/8/2017

The latest report from the Treatment Action Group on funding trends for global tuberculosis research and development shows there has been increases in spending on TB research, but overall funding remains inadequate for achieving global goals to eliminate the epidemic by 2030.

Healthier World, Safer America: A US Government Roadmap for International Action to Prevent the Next Pandemic (PDF)

10/24/2017

This report from PATH analyzes the importance of developing a robust pipeline of new drugs, diagnostics, vaccines and other technologies for diseases likely to become pandemics, and outlines recommendations for action from the US government to prevent the next pandemic.